MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.
Saved in:
| Title: | MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer. |
|---|---|
| Authors: | Takamori S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Haratake N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan., Bhattacharya A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Atrayee_Bhattacharya@dfci.harvard.edu., Kikutake C; Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Ozawa H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shigeta K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Nakashoji A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Isozaki H; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shimokawa M; Department of Biostatistics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan., Suyama M; Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Hashinokuchi A; Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan., Takada K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Toyokawa G; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Yamada Y; Fukuoka Pathology Clinic, Fukuoka, Japan., Takenaka T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Taguchi K; Cancer Pathology Laboratory, NHO Kyushu Cancer Center, Fukuoka, Japan., Yamaguchi M; Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan., Yoshizumi T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Hata AN; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Kufe D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Donald_Kufe@dfci.harvard.edu. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 Nov 28; Vol. 10 (1), pp. 389. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2059-3635 |
|---|---|
| DOI: | 10.1038/s41392-025-02482-7 |
